Dr. Mao-Draayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
28595 Orchard Lake Rd
Ste 200
Farmington Hills, MI 48334Phone+1 248-553-0010Fax+1 248-553-5957
Education & Training
- University of Vermont Medical CenterResidency, Neurology, 2000 - 2003
- Texas Tech University Health Sciences Center at LubbockInternship, Transitional Year, 1999 - 2000
- Peking Union Medical CollegeClass of 1990
Certifications & Licensure
- MI State Medical License 2012 - 2025
- OK State Medical License 2024 - 2025
- VT State Medical License 2000 - 2012
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Mechanistic Studies of Teriflunomide in RRMS Start of enrollment: 2018 Apr 17
Publications & Presentations
PubMed
- 25 citationsCD6 is a target for cancer immunotherapy.Jeffrey H. Ruth, Mikel Gurrea-Rubio, Kalana S. Athukorala, Stephanie M. Rasmussen, Daniel P. Weber
JCI Insight. 2021-03-08 - 47 citationsCurrent and Future Biomarkers in Multiple Sclerosis.Jennifer Yang, Maysa Hamade, Qi Wu, Qin Wang, Robert Axtell
International Journal of Molecular Sciences. 2022-05-24 - 39 citationsProgressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients.Allison Lm Jordan, Jennifer Yang, Caitlyn J Fisher, Michael K Racke, Yang Mao-Draayer
Multiple Sclerosis. 2020-08-18
Press Mentions
- OMRF Receives $3.8 Million to Study Autoimmune DiseasesAugust 12th, 2024
- OMRF Welcomes New MS Neurologist-ScientistJune 6th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: